Innovation Pharmaceuticals Inc (IPIX)

[pix]

I am quite nice invested into ctix, and Cant wait for the start of dosing.
The last pr of ctix was essentially very encouraging,
As they stated that DF is basially mapping the individuals tumors-
Which means, that they know about the p53 status of each patient.
So ctix is dealing with a theragnostic approach.
As well very interesting will Be the appearence of the potential biomarker p21,
Which could give a pretty fast signal, that the Basic concept of kevetrin is working
In patients.

Exciting Times ahead!!!!

All the Best,

Ingo